- Report
- April 2025
- 50 Pages
Global
From €2425EUR$2,650USD£2,107GBP
- Report
- September 2024
- 100 Pages
Global
From €5445EUR$5,950USD£4,731GBP
- Report
- May 2024
- 140 Pages
Global
From €5947EUR$6,499USD£5,167GBP
- Drug Pipelines
- July 2024
- 150 Pages
Global
From €3432EUR$3,750USD£2,982GBP
- Report
- March 2024
- 397 Pages
Global
From €7275EUR$7,950USD£6,321GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1144EUR$1,250USD£994GBP
Iloperidone is a medication used to treat mental disorders such as schizophrenia and bipolar disorder. It is a type of atypical antipsychotic, which works by blocking certain receptors in the brain to reduce symptoms such as hallucinations, delusions, and disorganized thinking. Iloperidone is generally well-tolerated and has fewer side effects than other antipsychotics. It is available in tablet and oral suspension form.
Iloperidone is a relatively new medication, and is not as widely used as other antipsychotics. However, it is gaining popularity due to its effectiveness and fewer side effects. It is also used off-label to treat other mental disorders such as depression and anxiety.
Some companies in the Iloperidone market include Sun Pharmaceutical Industries, Intas Pharmaceuticals, Dr. Reddy's Laboratories, and Lupin Pharmaceuticals. Show Less Read more